State Street
VERA icon

State Street’s Vera Therapeutics VERA Stock Holding History

State Street’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$135M Buy
3,363,638
+687,038
+26% +$29.6M ﹤0.01% 1194
2025
Q4 		$136M Buy
2,676,600
+343,017
+15% +$12.2M ﹤0.01% 1177
2025
Q3 		$67.8M Buy
2,333,583
+315,900
+16% +$7.31M ﹤0.01% 1574
2025
Q2 		$47.5M Sell
2,017,683
-65,365
-3% -$1.47M ﹤0.01% 1705
2025
Q1 		$50M Buy
2,083,048
+56,696
+3% +$1.82M ﹤0.01% 1630
2024
Q4 		$85.7M Buy
2,026,352
+202,545
+11% +$8.97M ﹤0.01% 1432
2024
Q3 		$80.6M Sell
1,823,807
-331,746
-15% -$12.6M ﹤0.01% 1454
2024
Q2 		$78M Sell
2,155,553
-195,174
-8% -$7.74M ﹤0.01% 1424
2024
Q1 		$101M Buy
2,350,727
+169,669
+8% +$6.05M ﹤0.01% 1297
2023
Q4 		$33.5M Buy
2,181,058
+453,412
+26% +$5.76M ﹤0.01% 1918
2023
Q3 		$23.7M Buy
1,727,646
+1,151,097
+200% +$19.7M ﹤0.01% 2062
2023
Q2 		$9.25M Buy
576,549
+272,402
+90% +$2.46M ﹤0.01% 2684
2023
Q1 		$2.36M Buy
304,147
+47,451
+18% +$366K ﹤0.01% 3287
2022
Q4 		$4.97M Buy
256,696
+6,913
+3% +$125K ﹤0.01% 3046
2022
Q3 		$5.32M Buy
249,783
+27,528
+12% +$515K ﹤0.01% 3028
2022
Q2 		$3.02M Buy
222,255
+53,498
+32% +$934K ﹤0.01% 3337
2022
Q1 		$3.96M Buy
168,757
+45,484
+37% +$979K ﹤0.01% 3296
2021
Q4 		$3.29M Buy
123,273
+48,018
+64% +$1.06M ﹤0.01% 3448
2021
Q3 		$1.31M Buy
+75,255
New +$1.35M ﹤0.01% 3729

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

State Street's VERA Position: Q1 2026 in Review

State Street increased its Vera Therapeutics (VERA) stake by 26% in Q1 2026, buying an estimated $29.6M and bringing the position to 3,363,638 shares worth $135M. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

State Street first reported a position in VERA in Q3 2021 and has held it in 19 quarters since. The position peaked at $136M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • State Street held 3,363,638 shares of Vera Therapeutics worth $135M as of Q1 2026.
  • State Street bought 687,038 Vera Therapeutics shares in Q1 2026, an estimated $29.6M.
  • Vera Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1194 holding.
  • State Street first reported a position in Vera Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • State Street's Vera Therapeutics position peaked at $136M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.